Home » Topics » Conferences

Conferences
RSS

More on Lilly's GH secretagogue program, including clinical candidate

Sep. 1, 1999

Ouabain analogue LND-623 is a more effective and less toxic inotropic agent

Sep. 1, 1999

Spironolactone continues to provide benefits in patients with heart failure

Sep. 1, 1999

5-ht6 receptor function under study at SmithKline Beecham

Aug. 31, 1999

DuPont team presents new cdk inhibitors at ACS meeting

Aug. 31, 1999

ETA antagonist TA-0201 protects against deleterious effects of MI in dogs

Aug. 31, 1999

ME-3230, an orally active prodrug of a potent gpIIb/IIIa antagonist

Aug. 31, 1999

Preclinical and mechanism of action studies support efficacy of the NHE-1 inhibitor cariporide

Aug. 31, 1999

U of M research team studies new compounds for imaging prostate cancer

Aug. 30, 1999

Final results of REACH-1 now in, support efficacy of bosentan in CHF

Aug. 30, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...